적합성 웨어러블 전극: 제작에서 전기생리학적 평가에 이르기까지

Executive Industry Relevance

Conformable wearable electrodes address the critical need for high-fidelity, long-duration electrophysiological monitoring in decentralized clinical trials and remote patient monitoring. By enabling reliable signal acquisition from skin-interfaced sensors, this method supports early-phase target validation and mechanistic de-risking in neuroscience and cardiovascular discovery programs. The scalable fabrication approach using PEDOT:PSS on off-the-shelf substrates facilitates integration into discovery workflows requiring reproducible, quantitative biosignal readouts.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of therapeutic hypotheses through quantitative measurement of neurogenic, cardiac, and muscular activity in human models.
• Operational Value: Supports biological de-risking by providing reproducible electrophysiological readouts that clarify target engagement and pathway modulation.
• Predictive Value: Generates translational biomarker data (e.g., EEG alpha rhythms, ECG R-wave intervals) to inform portfolio triage and lead selection.

Screening & Assay Development

• Assay Readiness: Produces standardized, low-impedance cutaneous interfaces suitable for high-throughput electrophysiological screening in discovery settings.
• Quantitative Output: Delivers impedance spectroscopy and time-domain signal metrics that enable assay standardization and inter-lab comparability.
• Platform Scalability: Leverages inkjet printing on flexible substrates to support reproducible electrode fabrication across multiple model systems and screening campaigns.

Translational & Preclinical Research

• Disease Relevance: Facilitates continuous monitoring of EEG, ECG, EMG, and EDA in preclinical models to align with clinical endpoints.
• Mechanistic De-risking: Provides objective, quantifiable electrophysiological endpoints to reduce uncertainty in target mechanism validation.
• Translational Continuity: Bridges discovery and preclinical stages by enabling consistent signal acquisition from ex vivo to in vivo systems.

Pipeline & Workflow Integration

The method fits within the discovery continuum from target hypothesis testing through lead identification to preclinical validation, particularly for indications involving neuromodulation, cardiac safety, or stress-response biomarkers.

• Discovery Biology: Supports hypothesis testing via quantitative biosignal acquisition that clarifies functional target activity in human-derived systems.
• Screening: Enables assay-ready electrode fabrication with reproducible impedance profiles for reliable compound effect detection.
• Analytics: Generates time-series and frequency-domain electrophysiological data (e.g., power spectra, peak amplitudes) for comparative condition analysis.
• Translational Research: Aligns with biomarker-driven advancement by capturing clinically relevant signals such as heart rate variability and skin conductance responses.
• Enterprise Reuse: Establishes a reusable fabrication and characterization platform adaptable across therapeutic areas and discovery sites.

Operational & Enterprise Impact

• Scientific Value: Enhances predictive confidence through high-fidelity, conformal electrophysiological recordings that reduce mechanistic ambiguity.
• Operational Value: Delivers standardized, scalable sensor fabrication with quantifiable impedance and signal-to-noise performance.
• Strategic Value: Improves go/no-go decisions by providing objective, quantitative biosignal data early in the discovery pipeline.
• Portfolio Impact: Enables risk-adjusted prioritization via translatable electrophysiological endpoints linked to clinical outcomes.

Implementation Considerations

• Requires expertise in organic electronics, skin-electrode interface design, and biosignal acquisition.
• Needs access to inkjet printing equipment, impedance spectroscopy systems, and biopotential amplifiers.
• Demands standardization of skin preparation, electrode placement, and signal conditioning protocols across teams.
• Involves adaptation considerations for varying skin properties, substrate flexibility, and long-term wearability.
• Limited by signal attenuation in high-motion environments and the need for validation against clinical gold standards.

Biopharma FAQs